Illumineuro “Einstein” Peptide Blend

Illumineuro Peptide Blend (Einstein)

The Einstein Peptide Blend, widely cataloged in neurological research as Illumineuro, is a premier multi-peptide formulation engineered for advanced preclinical studies of the central nervous system. This sophisticated blend integrates four of the most prominent neuroactive peptides—N-acetyl Semax, N-acetyl Selank, Pinealon, and PE-22-28—into a single, high-purity vial to support multifaceted research into neuroplasticity, stress modulation, and synaptic efficiency.

By consolidating these compounds, the Einstein Peptide Blend allows investigators to explore synergistic pathways within a controlled laboratory environment. Supplied as a stable, lyophilized powder by Protide Health, this formulation is optimized for researchers requiring standardized tools for complex cognitive modeling.

• Peptide Type: Multi-Peptide Neuro-Research Formulation

• Vial Content: 20mg N-acetyl Semax, 10mg N-acetyl Selank, 10mg Pinealon, 10mg PE-22-28

• Form: Lyophilized (Freeze-Dried) for maximum biochemical stability

Illumineuro Peptide Blend (Einstein): Technical Overview & Research Properties

The Illumineuro Peptide Blend (Einstein) is synthesized to investigate the signaling properties of specific neuropeptide fragments. This formulation is frequently utilized to study the regulation of neurotrophic factors and the modulation of the hypothalamus-pituitary-adrenal (HPA) axis.

Each component is N-acetylated where applicable to enhance stability and resistance to enzymatic degradation within experimental models. Like all high-tier research compounds, Illumineuro is supplied in a vacuum-sealed, freeze-dried state to ensure molecular integrity during transit and storage.

Composition and Synergistic Architecture of Illumineuro Blend

The Illumineuro formula is unique in its ability to target multiple neurological pathways simultaneously. Researchers utilize this blend to investigate the following individual components:

1. N-acetyl Semax (20mg): An analog of ACTH fragments studied for its role in upregulating Brain-Derived Neurotrophic Factor (BDNF) and fostering neuroplasticity. Ashmarin et al., 1997

2. N-acetyl Selank (10mg): A peptide analog researched for its influence on GABAergic signaling and its potential to modulate stress-response behaviors. Kozlovskiy et al., 2010

3. Pinealon (10mg): A short-chain tripeptide investigated for its ability to penetrate cellular membranes and its role in protecting neurons from oxidative stress. Khavinson et al., 2012

4. PE-22-28 (10mg): A specific peptide fragment studied for its interaction with TREK-1 potassium channels and its influence on hippocampal signaling. Myasoedov et al., 2011

Mechanism of Action: Multi-Targeted Neuroregulation

In laboratory models, the Einstein Peptide Blend is thought to work by influencing the efficiency of signal transmission between neurons. This combined signaling effect is a primary focus for studies involving cognitive performance and emotional regulation pathways.

Research Insight: Components like Semax are often researched for their “neurotrophic” support, while Selank is explored for its role in modulating neurotransmitter levels. The addition of Pinealon and PE-22-28 allows researchers to observe how cellular resilience and synaptic efficiency interact within a single experimental arm.

Advanced Research Applications for Illumineuro Peptide

1. Cognitive Performance & Neuroplasticity

Preclinical studies on the Einstein Peptide Blend focus on the acquisition of new behaviors and memory retention. Researchers track changes in neurotrophic factor expression to understand how these peptides influence the brain’s ability to form new neural connections. Ashmarin et al., 1997

2. Stress-Response & Neurochemical Signaling

The Illumineuro blend provides a unique tool for studying the biochemistry of the stress response. Selank-based research focuses on how peptides can modulate neural activity without the sedative profile of traditional pharmacological agents. Kozlovskiy et al., 2010

3. Neuronal Aging & Resilience

Through the inclusion of Pinealon, the Einstein Peptide Blend is a primary tool for researchers investigating the aging process within neural tissues. Studies measure markers of cell survival and the modulation of gene expression related to cellular longevity. Khavinson et al., 2012

Specifications Table: Illumineuro Peptide Blend (Einstein)

Parameter	Technical Details
Product Name	Illumineuro Peptide Blend (Einstein)
Components	Semax, Selank, Pinealon, PE-22-28
Total Vial Weight	50mg (Active Peptide)
Purity Grade	99%+ (Verified via HPLC/MS)
Solubility	Reconstitute with Bacteriostatic Water
Storage Temperature	-20°C (Frozen)
Intended Use	Laboratory Research Only

FAQs: Illumineuro Peptide Blend (Einstein)

What makes the Illumineuro Peptide Blend unique?

Unlike single-peptide solutions, the Illumineuro Peptide Blend allows investigators to study the synergistic interactions between BDNF upregulation, GABA modulation, and TREK-1 channel signaling within a single model.

Is Illumineuro the same as the Einstein Blend?

Yes. Illumineuro is the alternate research designation for this specific 20/10/10/10mg combination.

How is Illumineuro Blend stored for research stability?

In lab environments, it is stored as a lyophilized powder at -20°C. Reconstituted solutions should be handled according to institutional SOPs to minimize degradation.

Where can I buy Illumineuro Peptide Blend online?

Qualified researchers can purchase the Illumineuro Peptide Blend (Einstein) through Protide Health, where every batch is third-party tested for 99% purity.

Conclusion: Summary for Researchers

The Illumineuro Peptide Blend (Einstein) represents a high-value tool for modern neuroscience. By integrating Semax, Selank, Pinealon, and PE-22-28, it provides a multifaceted platform for exploring the intersection of neuroprotection, cognitive performance, and stress signaling. Available exclusively for laboratory use, this blend is a vital asset for advancing preclinical neurological discovery.

Citations

• Ashmarin IP et al., 1997. Semax effects in learning and memory models. PubMed.

• Kozlovskiy SA et al., 2010. Selank and anxiety-related behavior studies. PubMed.

• Myasoedov NF et al., 2011. Neuropeptide regulation and neurotrophic signaling. PubMed.

• Khavinson VKh et al., 2012. Pinealon peptide and neuronal aging models. PubMed.

Legal Disclaimer

The Illumineuro Peptide Blend (Einstein) is intended for laboratory research purposes only. It is not approved by the FDA for human consumption, medical use, or self-administration. All research must be conducted by qualified professionals within a controlled environment. Researchers must comply with all applicable local, state, and federal regulations, including obtaining necessary approvals for experimental use. Products sold by Protide Health are for laboratory research purposes only and are not intended for human consumption, medical use, or veterinary use.